NCT02066805View on ClinicalTrials.gov

Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
XGEVA Off-label Use
Interventions
DRUG

Database assessment of off-label XGEVA use

No intervention is planned during this study as it involves analyses of patient electronic records from Northern Jutland Region and Copenhagen

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
collaborator

University of Aarhus

OTHER

lead

Amgen

INDUSTRY